-
1
-
-
85051260971
-
IDF diabetes atlas-7th edition
-
International Diabetes Federation.
-
International Diabetes Federation. IDF Diabetes Atlas-7th Edition. Diabetes Atlas http:// www. diabetesatlas. org/ (2015).
-
(2015)
Diabetes Atlas
-
-
-
2
-
-
85016474227
-
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: A meta-analysis of individual participant data from randomised controlled trials
-
Zoungas, S. et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol 5, 431-437 (2017).
-
(2017)
Lancet Diabetes Endocrinol
, vol.5
, pp. 431-437
-
-
Zoungas, S.1
-
3
-
-
33750469241
-
Standards of medical care in diabetes 2017
-
American Diabetes, A.
-
American Diabetes, A. Standards of medical care in diabetes 2017. Diabetes Care 40, S1-S106 (2017).
-
(2017)
Diabetes Care
, vol.40
, pp. S1-S106
-
-
-
4
-
-
79952273819
-
Long-term effects of intensive glucose lowering on cardiovascular outcomes
-
Group, A. S. et al
-
Group, A. S. et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N. Engl. J. Med. 364, 818-828 (2011).
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 818-828
-
-
-
5
-
-
85014619872
-
Association of type 1 diabetes versus type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood
-
Dabelea, D. et al. Association of type 1 diabetes versus type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA 317, 825-835 (2017).
-
(2017)
JAMA
, vol.317
, pp. 825-835
-
-
Dabelea, D.1
-
6
-
-
77950601556
-
Pathologic classification of diabetic nephropathy
-
Tervaert, T. W. et al. Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21, 556-563 (2010).
-
(2010)
J. Am. Soc. Nephrol.
, vol.21
, pp. 556-563
-
-
Tervaert, T.W.1
-
8
-
-
85019403451
-
Assessment of global kidney health care status
-
Bello, A. K. et al. Assessment of global kidney health care status. JAMA 317, 1864-1881 (2017).
-
(2017)
JAMA
, vol.317
, pp. 1864-1881
-
-
Bello, A.K.1
-
9
-
-
85013870239
-
US Renal Data System 2016 Annual Data Report: Epidemiology of kidney disease in the United States
-
Saran, R. et al. US Renal Data System 2016 Annual Data Report: Epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 69, A7-A8 (2017).
-
(2017)
Am. J. Kidney Dis.
, vol.69
, pp. A7-A8
-
-
Saran, R.1
-
10
-
-
84978128484
-
Global Prevalence of chronic kidney disease-a systematic review and meta-analysis
-
Hill, N. R. et al. Global Prevalence of chronic kidney disease-a systematic review and meta-analysis. PLoS ONE 11, e0158765 (2016).
-
(2016)
PLoS ONE
, vol.11
, pp. e0158765
-
-
Hill, N.R.1
-
11
-
-
84899563637
-
Diabetic nephropathy: Is it time yet for routine kidney biopsy?
-
Gonzalez Suarez, M. L., Thomas, D. B., Barisoni, L. & Fornoni, A. Diabetic nephropathy: Is it time yet for routine kidney biopsy? World J. Diabetes 4, 245-255 (2013).
-
(2013)
World J. Diabetes
, vol.4
, pp. 245-255
-
-
Gonzalez Suarez, M.L.1
Thomas, D.B.2
Barisoni, L.3
Fornoni, A.4
-
12
-
-
84885228643
-
The modern spectrum of renal biopsy findings in patients with diabetes
-
Sharma, S. G. et al. The modern spectrum of renal biopsy findings in patients with diabetes. Clin. J. Am. Soc. Nephrol. 8, 1718-1724 (2013).
-
(2013)
Clin. J. Am. Soc. Nephrol.
, vol.8
, pp. 1718-1724
-
-
Sharma, S.G.1
-
13
-
-
85016193736
-
Renal biopsy in patients with diabetes: A pooled meta-analysis of 48 studies
-
Fiorentino, M. et al. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol. Dial Transplant. 32, 97-110 (2017).
-
(2017)
Nephrol. Dial Transplant.
, vol.32
, pp. 97-110
-
-
Fiorentino, M.1
-
14
-
-
85018660023
-
Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy
-
Levin, A. et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 390, 1888-1917 (2017).
-
(2017)
Lancet
, vol.390
, pp. 1888-1917
-
-
Levin, A.1
-
15
-
-
85047123357
-
Diabetic Kidney Disease. the mechanisms and pathophysiology underlying diabetic nephropathy and its progression
-
[No authors listed. ]
-
[No authors listed. ] Diabetic Kidney Disease. The mechanisms and pathophysiology underlying diabetic nephropathy and its progression. National Institute of Diabetes and Digestive and Kidney Diseases https:// www. niddk. nih. gov/research-funding/researchprograms/ diabetic-kidney-disease (2018).
-
(2018)
National Institute of Diabetes and Digestive and Kidney Diseases
-
-
-
16
-
-
84928210058
-
Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China
-
Wan, Q., Xu, Y. & Dong, E. Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China. J. Diabetes 7, 307-314 (2015).
-
(2015)
J. Diabetes
, vol.7
, pp. 307-314
-
-
Wan, Q.1
Xu, Y.2
Dong, E.3
-
17
-
-
85012031635
-
Diabetes control and the risks of ESRD and mortality in patients with CKD
-
Navaneethan, S. D. et al. Diabetes control and the risks of ESRD and mortality in patients with CKD. Am. J. Kidney Dis. 70, 191-198 (2017).
-
(2017)
Am. J. Kidney Dis.
, vol.70
, pp. 191-198
-
-
Navaneethan, S.D.1
-
18
-
-
84979884860
-
Cardiac and renovascular complications in type 2 diabetes-is there hope?
-
Ingelfinger, J. R. & Rosen, C. J. Cardiac and renovascular complications in type 2 diabetes-is there hope? N. Engl. J. Med. 375, 380-382 (2016).
-
(2016)
N. Engl. J. Med.
, vol.375
, pp. 380-382
-
-
Ingelfinger, J.R.1
Rosen, C.J.2
-
19
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
-
Study (UKPDS) Group
-
Prospective Diabetes, U. K. Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865 (1998).
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
Prospective Diabetes, U.K.1
-
20
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861-869 (2001).
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
-
21
-
-
84944800184
-
Empagliflozin, Cardiovascular outcomes, and mortality in type 2 diabetes
-
Zinman, B. et al. Empagliflozin, Cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117-2128 (2015).
-
(2015)
N. Engl. J. Med.
, vol.373
, pp. 2117-2128
-
-
Zinman, B.1
-
22
-
-
85023777061
-
Canagliflozin and cardiovascular and renal events in type 2 diabetes
-
Neal, B. et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N. Engl. J. Med. 377, 644-657 (2017).
-
(2017)
N. Engl. J. Med.
, vol.377
, pp. 644-657
-
-
Neal, B.1
-
23
-
-
84978839381
-
Liraglutide and cardiovascular outcomes in type 2 diabetes
-
Marso, S. P. et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311-322 (2016).
-
(2016)
N. Engl. J. Med.
, vol.375
, pp. 311-322
-
-
Marso, S.P.1
-
24
-
-
85018394748
-
Mortality and cardiovascular disease in type 1 and type 2 diabetes
-
Rawshani, A. et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N. Engl. J. Med. 376, 1407-1418 (2017).
-
(2017)
N. Engl. J. Med.
, vol.376
, pp. 1407-1418
-
-
Rawshani, A.1
-
25
-
-
84898602820
-
Changes in diabetes-related complications in the United States, 1990-2010
-
Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990-2010. N. Engl. J. Med. 370, 1514-1523 (2014).
-
(2014)
N. Engl. J. Med.
, vol.370
, pp. 1514-1523
-
-
Gregg, E.W.1
-
26
-
-
0034951087
-
Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients
-
Parving, H. H., Hommel, E., Jensen, B. R. & Hansen, H. P. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int. 60, 228-234 (2001).
-
(2001)
Kidney Int.
, vol.60
, pp. 228-234
-
-
Parving, H.H.1
Hommel, E.2
Jensen, B.R.3
Hansen, H.P.4
-
27
-
-
84863022503
-
Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS/ db/db mice
-
Zhang, M. Z. et al. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS?/? db/db mice. Am. J. Physiol. Renal Physiol. 302, F433-F438 (2012).
-
(2012)
Am. J. Physiol. Renal Physiol.
, vol.302
, pp. F433-F438
-
-
Zhang, M.Z.1
-
28
-
-
84979895487
-
Empagliflozin and progression of kidney disease in type 2 diabetes
-
Wanner, C. et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N. Engl. J. Med. 375, 323-334 (2016).
-
(2016)
N. Engl. J. Med.
, vol.375
, pp. 323-334
-
-
Wanner, C.1
-
29
-
-
85028547742
-
Liraglutide and renal outcomes in type 2 diabetes
-
Mann, J. F. E. et al. Liraglutide and renal outcomes in type 2 diabetes. N. Engl. J. Med. 377, 839-848 (2017).
-
(2017)
N. Engl. J. Med.
, vol.377
, pp. 839-848
-
-
Mann, J.F.E.1
-
30
-
-
84996993010
-
Nephron protection in diabetic kidney disease
-
Anders, H. J., Davis, J. M. & Thurau, K. Nephron protection in diabetic kidney disease. N. Engl. J. Med. 375, 2096-2098 (2016).
-
(2016)
N. Engl. J. Med.
, vol.375
, pp. 2096-2098
-
-
Anders, H.J.1
Davis, J.M.2
Thurau, K.3
-
31
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis, E. J. et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851-860 (2001).
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
-
32
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
Parving, H. H. et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345, 870-878 (2001).
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 870-878
-
-
Parving, H.H.1
-
33
-
-
84890946148
-
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease
-
de Zeeuw, D. et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N. Engl. J. Med. 369, 2492-2503 (2013).
-
(2013)
N. Engl. J. Med.
, vol.369
, pp. 2492-2503
-
-
De Zeeuw, D.1
-
34
-
-
84869492851
-
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
-
Parving, H. H. et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N. Engl. J. Med. 367, 2204-2213 (2012).
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 2204-2213
-
-
Parving, H.H.1
-
35
-
-
85021850104
-
Anti-TGF-?1 antibody therapy in patients with diabetic nephropathy
-
Voelker, J. et al. Anti-TGF-?1 antibody therapy in patients with diabetic nephropathy. J. Am. Soc. Nephrol. 28, 953-962 (2017).
-
(2017)
J. Am. Soc. Nephrol.
, vol.28
, pp. 953-962
-
-
Voelker, J.1
-
36
-
-
80053922229
-
Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death
-
Berhane, A. M., Weil, E. J., Knowler, W. C., Nelson, R. G. & Hanson, R. L. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin. J. Am. Soc. Nephrol. 6, 2444-2451 (2011).
-
(2011)
Clin. J. Am. Soc. Nephrol.
, vol.6
, pp. 2444-2451
-
-
Berhane, A.M.1
Weil, E.J.2
Knowler, W.C.3
Nelson, R.G.4
Hanson, R.L.5
-
37
-
-
84874644599
-
KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease
-
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.
-
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 1-150 (2013).
-
(2013)
Kidney Int. Suppl.
, vol.3
, pp. 1-150
-
-
-
38
-
-
85033795749
-
Predictors for the development of microalbuminuria and interaction with renal function
-
Chatzikyrkou, C. et al. Predictors for the development of microalbuminuria and interaction with renal function. J. Hypertens. 35, 2501-2509 (2017).
-
(2017)
J. Hypertens.
, vol.35
, pp. 2501-2509
-
-
Chatzikyrkou, C.1
-
39
-
-
84866525978
-
Clinical implications of pathologic diagnosis and classification for diabetic nephropathy
-
Oh, S. W. et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res. Clin. Pract. 97, 418-424 (2012).
-
(2012)
Diabetes Res. Clin. Pract.
, vol.97
, pp. 418-424
-
-
Oh, S.W.1
-
40
-
-
0037213037
-
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
-
Adler, A. I. et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 63, 225-232 (2003).
-
(2003)
Kidney Int.
, vol.63
, pp. 225-232
-
-
Adler, A.I.1
-
41
-
-
85021677814
-
Microalbuminuria in type-2 diabetes mellitus; The tip of iceberg of diabetic complications
-
Ahmad, T., Ulhaq, I., Mawani, M. & Islam, N. Microalbuminuria in type-2 diabetes mellitus; the tip of iceberg of diabetic complications. Pak. J. Med. Sci. 33, 519-523 (2017).
-
(2017)
Pak. J. Med. Sci.
, vol.33
, pp. 519-523
-
-
Ahmad, T.1
Ulhaq, I.2
Mawani, M.3
Islam, N.4
-
42
-
-
0021990584
-
Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulindependent diabetes
-
Wiseman, M. J., Saunders, A. J., Keen, H. & Viberti, G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulindependent diabetes. N. Engl. J. Med. 312, 617-621 (1985).
-
(1985)
N. Engl. J. Med.
, vol.312
, pp. 617-621
-
-
Wiseman, M.J.1
Saunders, A.J.2
Keen, H.3
Viberti, G.4
-
43
-
-
84906695117
-
Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria
-
Skupien, J. et al. Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria. J. Am. Soc. Nephrol. 25, 2916-2925 (2014).
-
(2014)
J. Am. Soc. Nephrol.
, vol.25
, pp. 2916-2925
-
-
Skupien, J.1
-
44
-
-
84902547592
-
Is diabetic nephropathy reversible?
-
Fioretto, P., Barzon, I. & Mauer, M. Is diabetic nephropathy reversible? Diabetes Res. Clin. Pract. 104, 323-328 (2014).
-
(2014)
Diabetes Res. Clin. Pract.
, vol.104
, pp. 323-328
-
-
Fioretto, P.1
Barzon, I.2
Mauer, M.3
-
45
-
-
85020448574
-
Glomerular hyperfiltration in diabetes: Mechanisms, clinical significance, and treatment
-
Tonneijck, L. et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J. Am. Soc. Nephrol. 28, 1023-1039 (2017).
-
(2017)
J. Am. Soc. Nephrol.
, vol.28
, pp. 1023-1039
-
-
Tonneijck, L.1
-
46
-
-
84929223377
-
Genetics of diabetic nephropathy: A long road of discovery
-
McKnight, A. J., Duffy, S. & Maxwell, A. P. Genetics of diabetic nephropathy: a long road of discovery. Curr. Diab Rep. 15, 41 (2015).
-
(2015)
Curr. Diab Rep.
, vol.15
, pp. 41
-
-
McKnight, A.J.1
Duffy, S.2
Maxwell, A.P.3
-
47
-
-
84921374064
-
The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus
-
Vallon, V. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu. Rev. Med. 66, 255-270 (2015).
-
(2015)
Annu. Rev. Med.
, vol.66
, pp. 255-270
-
-
Vallon, V.1
-
48
-
-
85035215727
-
A more tubulocentric view of diabetic kidney disease
-
Zeni, L., Norden, A. G. W., Cancarini, G. & Unwin, R. J. A more tubulocentric view of diabetic kidney disease. J. Nephrol. 30, 701-717 (2017).
-
(2017)
J. Nephrol.
, vol.30
, pp. 701-717
-
-
Zeni, L.1
Norden, A.G.W.2
Cancarini, G.3
Unwin, R.J.4
-
50
-
-
84922479673
-
Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: The Hoorn study
-
van Sloten, T. T. et al. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study. Hypertension 64, 1299-1305 (2014).
-
(2014)
Hypertension
, vol.64
, pp. 1299-1305
-
-
Van Sloten, T.T.1
-
51
-
-
84902795323
-
Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications [Spanish]
-
Frati Munari, A. C. Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications [Spanish]. Arch. Cardiol. Mex. 84, 110-116 (2014).
-
(2014)
Arch. Cardiol. Mex.
, vol.84
, pp. 110-116
-
-
Frati Munari, A.C.1
-
52
-
-
84994098499
-
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
-
Fu, J., Lee, K., Chuang, P. Y., Liu, Z. & He, J. C. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am. J. Physiol. Renal Physiol. 308, F287-F297 (2015).
-
(2015)
Am. J. Physiol. Renal Physiol.
, vol.308
, pp. F287-F297
-
-
Fu, J.1
Lee, K.2
Chuang, P.Y.3
Liu, Z.4
He, J.C.5
-
53
-
-
33644759419
-
Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo
-
Nieuwdorp, M. et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55, 480-486 (2006).
-
(2006)
Diabetes
, vol.55
, pp. 480-486
-
-
Nieuwdorp, M.1
-
54
-
-
0026680435
-
Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species
-
Kashihara, N., Watanabe, Y., Makino, H., Wallner, E. I. & Kanwar, Y. S. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc. Natl Acad. Sci. USA 89, 6309-6313 (1992).
-
(1992)
Proc. Natl Acad. Sci. USA
, vol.89
, pp. 6309-6313
-
-
Kashihara, N.1
Watanabe, Y.2
Makino, H.3
Wallner, E.I.4
Kanwar, Y.S.5
-
55
-
-
84872193981
-
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
-
Bock, F. et al. Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc. Natl Acad. Sci. USA 110, 648-653 (2013).
-
(2013)
Proc. Natl Acad. Sci. USA
, vol.110
, pp. 648-653
-
-
Bock, F.1
-
56
-
-
35948934636
-
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis
-
Isermann, B. et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat. Med. 13, 1349-1358 (2007).
-
(2007)
Nat. Med.
, vol.13
, pp. 1349-1358
-
-
Isermann, B.1
-
57
-
-
0037407520
-
Extracellular matrix metabolism in diabetic nephropathy
-
Mason, R. M. & Wahab, N. A. Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14, 1358-1373 (2003).
-
(2003)
J. Am. Soc. Nephrol.
, vol.14
, pp. 1358-1373
-
-
Mason, R.M.1
Wahab, N.A.2
-
58
-
-
85020453192
-
Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy
-
Kriz, W. et al. Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 312, F1101-F1111 (2017).
-
(2017)
Am. J. Physiol. Renal Physiol.
, vol.312
, pp. F1101-F1111
-
-
Kriz, W.1
-
59
-
-
0034608948
-
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice
-
Ziyadeh, F. N. et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc. Natl Acad. Sci. USA 97, 8015-8020 (2000).
-
(2000)
Proc. Natl Acad. Sci. USA
, vol.97
, pp. 8015-8020
-
-
Ziyadeh, F.N.1
-
60
-
-
33644995630
-
High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes
-
Bai, Y. et al. High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes. Cell Physiol. Biochem. 17, 57-68 (2006).
-
(2006)
Cell Physiol. Biochem.
, vol.17
, pp. 57-68
-
-
Bai, Y.1
-
61
-
-
0035523642
-
Role of mesangial expansion in the pathogenesis of diabetic nephropathy
-
Dalla Vestra, M., Saller, A., Mauer, M. & Fioretto, P. Role of mesangial expansion in the pathogenesis of diabetic nephropathy. J. Nephrol. 14(Suppl. 4), S51-S57 (2001).
-
(2001)
J. Nephrol.
, vol.14
, pp. S51-S57
-
-
Dalla Vestra, M.1
Saller, A.2
Mauer, M.3
Fioretto, P.4
-
62
-
-
0031029379
-
Podocyte loss and progressive glomerular injury in type II diabetes
-
Pagtalunan, M. E. et al. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 99, 342-348 (1997).
-
(1997)
J. Clin. Invest.
, vol.99
, pp. 342-348
-
-
Pagtalunan, M.E.1
-
63
-
-
84864286521
-
Impact of high glucose and transforming growth factor-? on bioenergetic profiles in podocytes
-
Stieger, N. et al. Impact of high glucose and transforming growth factor-? on bioenergetic profiles in podocytes. Metabolism 61, 1073-1086 (2012).
-
(2012)
Metabolism
, vol.61
, pp. 1073-1086
-
-
Stieger, N.1
-
64
-
-
33644783770
-
Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy
-
Susztak, K., Raff, A. C., Schiffer, M. & Bottinger, E. P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55, 225-233 (2006).
-
(2006)
Diabetes
, vol.55
, pp. 225-233
-
-
Susztak, K.1
Raff, A.C.2
Schiffer, M.3
Bottinger, E.P.4
-
65
-
-
0031033557
-
Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus
-
Regoli, M. & Bendayan, M. Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus. Diabetologia 40, 15-22 (1997).
-
(1997)
Diabetologia
, vol.40
, pp. 15-22
-
-
Regoli, M.1
Bendayan, M.2
-
66
-
-
0034836835
-
Apoptosis in podocytes induced by TGF-? and Smad7
-
Schiffer, M. et al. Apoptosis in podocytes induced by TGF-? and Smad7. J. Clin. Invest. 108, 807-816 (2001).
-
(2001)
J. Clin. Invest.
, vol.108
, pp. 807-816
-
-
Schiffer, M.1
-
67
-
-
85016626296
-
SGLT2 Protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice
-
Wang, X. X. et al. SGLT2 Protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice. J. Biol. Chem. 292, 5335-5348 (2017).
-
(2017)
J. Biol. Chem.
, vol.292
, pp. 5335-5348
-
-
Wang, X.X.1
-
68
-
-
84937814929
-
Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys
-
Li, X. et al. Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys. J. Am. Soc. Nephrol. 26, 2361-2377 (2015).
-
(2015)
J. Am. Soc. Nephrol.
, vol.26
, pp. 2361-2377
-
-
Li, X.1
-
69
-
-
0345505674
-
Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II
-
Doublier, S. et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52, 1023-1030 (2003).
-
(2003)
Diabetes
, vol.52
, pp. 1023-1030
-
-
Doublier, S.1
-
70
-
-
79953840843
-
PKC mediates -arrestin2-dependent nephrin endocytosis in hyperglycemia
-
Quack, I. et al. PKC? mediates ?-arrestin2-dependent nephrin endocytosis in hyperglycemia. J. Biol. Chem. 286, 12959-12970 (2011).
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 12959-12970
-
-
Quack, I.1
-
71
-
-
77956302476
-
Podocytic PKC- is regulated in murine and human diabetes and mediates nephrin endocytosis
-
Tossidou, I. et al. Podocytic PKC-? is regulated in murine and human diabetes and mediates nephrin endocytosis. PLoS ONE 5, e10185 (2010).
-
(2010)
PLoS ONE
, vol.5
, pp. e10185
-
-
Tossidou, I.1
-
72
-
-
85000613473
-
CIN85 Deficiency prevents nephrin endocytosis and proteinuria in diabetes
-
Teng, B. et al. CIN85 Deficiency prevents nephrin endocytosis and proteinuria in diabetes. Diabetes 65, 3667-3679 (2016).
-
(2016)
Diabetes
, vol.65
, pp. 3667-3679
-
-
Teng, B.1
-
73
-
-
84924371283
-
Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy
-
Madhusudhan, T. et al. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nat. Commun. 6, 6496 (2015).
-
(2015)
Nat. Commun.
, vol.6
, pp. 6496
-
-
Madhusudhan, T.1
-
74
-
-
85027712509
-
Signal integration at the PI3Kp85-XBP1 hub endows coagulation protease activated protein C with insulin-like function
-
Madhusudhan, T. et al. Signal integration at the PI3Kp85-XBP1 hub endows coagulation protease activated protein C with insulin-like function. Blood 130, 1445-1455 (2017).
-
(2017)
Blood
, vol.130
, pp. 1445-1455
-
-
Madhusudhan, T.1
-
75
-
-
77957657608
-
Insulin signaling to the glomerular podocyte is critical for normal kidney function
-
Welsh, G. I. et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 12, 329-340 (2010).
-
(2010)
Cell Metab.
, vol.12
, pp. 329-340
-
-
Welsh, G.I.1
-
76
-
-
29144490392
-
Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene
-
Wharram, B. L. et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J. Am. Soc. Nephrol. 16, 2941-2952 (2005).
-
(2005)
J. Am. Soc. Nephrol.
, vol.16
, pp. 2941-2952
-
-
Wharram, B.L.1
-
77
-
-
84878425128
-
Podocyte mitosis-a catastrophe
-
Lasagni, L., Lazzeri, E., Shankland, S. J., Anders, H. J. & Romagnani, P. Podocyte mitosis-a catastrophe. Curr. Mol. Med. 13, 13-23 (2013).
-
(2013)
Curr. Mol. Med.
, vol.13
, pp. 13-23
-
-
Lasagni, L.1
Lazzeri, E.2
Shankland, S.J.3
Anders, H.J.4
Romagnani, P.5
-
78
-
-
84926644943
-
Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus
-
Fufaa, G. D. et al. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus. Nephrol. Dial. Transplant. 30, 599-606 (2015).
-
(2015)
Nephrol. Dial. Transplant.
, vol.30
, pp. 599-606
-
-
Fufaa, G.D.1
-
79
-
-
84951905077
-
Innate immunity in diabetes and diabetic nephropathy
-
Wada, J. & Makino, H. Innate immunity in diabetes and diabetic nephropathy. Nat. Rev. Nephrol. 12, 13-26 (2016).
-
(2016)
Nat. Rev. Nephrol.
, vol.12
, pp. 13-26
-
-
Wada, J.1
Makino, H.2
-
80
-
-
85016026911
-
C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
-
Menne, J. et al. C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria. Nephrol. Dial Transplant 32, 307-315 (2017).
-
(2017)
Nephrol. Dial Transplant
, vol.32
, pp. 307-315
-
-
Menne, J.1
-
81
-
-
84939483610
-
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: A randomised trial
-
de Zeeuw, D. et al. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol 3, 687-696 (2015).
-
(2015)
Lancet Diabetes Endocrinol
, vol.3
, pp. 687-696
-
-
De Zeeuw, D.1
-
82
-
-
26944480830
-
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice
-
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C. & Tesch, G. H. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J. Am. Soc. Nephrol. 16, 1711-1722 (2005).
-
(2005)
J. Am. Soc. Nephrol.
, vol.16
, pp. 1711-1722
-
-
Chow, F.Y.1
Nikolic-Paterson, D.J.2
Ozols, E.3
Atkins, R.C.4
Tesch, G.H.5
-
83
-
-
85027957604
-
An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
-
Sayyed, S. G. et al. An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int. 80, 68-78 (2011).
-
(2011)
Kidney Int.
, vol.80
, pp. 68-78
-
-
Sayyed, S.G.1
-
84
-
-
84920134906
-
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
-
Shahzad, K. et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 87, 74-84 (2015).
-
(2015)
Kidney Int.
, vol.87
, pp. 74-84
-
-
Shahzad, K.1
-
85
-
-
85007108941
-
Of inflammasomes and alarmins: IL-1? and IL-1? in kidney disease
-
Anders, H. J. Of inflammasomes and alarmins: IL-1? and IL-1? in kidney disease. J. Am. Soc. Nephrol. 27, 2564-2575 (2016).
-
(2016)
J. Am. Soc. Nephrol.
, vol.27
, pp. 2564-2575
-
-
Anders, H.J.1
-
86
-
-
84983319771
-
Targeting inflammation in diabetic kidney disease: Early clinical trials
-
Perez-Gomez, M. V. et al. Targeting inflammation in diabetic kidney disease: early clinical trials. Expert Opin. Invest. Drugs 25, 1045-1058 (2016).
-
(2016)
Expert Opin. Invest. Drugs
, vol.25
, pp. 1045-1058
-
-
Perez-Gomez, M.V.1
-
87
-
-
77649179433
-
NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?
-
Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10, 210-215 (2010).
-
(2010)
Nat. Rev. Immunol.
, vol.10
, pp. 210-215
-
-
Tschopp, J.1
Schroder, K.2
-
88
-
-
84903513560
-
Pattern recognition receptors and the inflammasome in kidney disease
-
Leemans, J. C., Kors, L., Anders, H. J. & Florquin, S. Pattern recognition receptors and the inflammasome in kidney disease. Nat. Rev. Nephrol. 10, 398-414 (2014).
-
(2014)
Nat. Rev. Nephrol.
, vol.10
, pp. 398-414
-
-
Leemans, J.C.1
Kors, L.2
Anders, H.J.3
Florquin, S.4
-
89
-
-
84994834565
-
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
-
Qiu, Y. Y. & Tang, L. Q. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacol. Res. 114, 251-264 (2016).
-
(2016)
Pharmacol. Res.
, vol.114
, pp. 251-264
-
-
Qiu, Y.Y.1
Tang, L.Q.2
-
90
-
-
85017299727
-
Caspase-1, but not caspase-3, promotes diabetic nephropathy
-
Shahzad, K. et al. Caspase-1, but not caspase-3, promotes diabetic nephropathy. J. Am. Soc. Nephrol. 27, 2270-2275 (2016).
-
(2016)
J. Am. Soc. Nephrol.
, vol.27
, pp. 2270-2275
-
-
Shahzad, K.1
-
91
-
-
85029568219
-
Antiinflammatory therapy with canakinumab for atherosclerotic disease
-
Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119-1131 (2017).
-
(2017)
N. Engl. J. Med.
, vol.377
, pp. 1119-1131
-
-
Ridker, P.M.1
-
92
-
-
29144453326
-
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
-
Nathan, D. M. et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353, 2643-2653 (2005).
-
(2005)
N. Engl. J. Med.
, vol.353
, pp. 2643-2653
-
-
Nathan, D.M.1
-
93
-
-
53349101264
-
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
-
El-Osta, A. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409-2417 (2008).
-
(2008)
J. Exp. Med.
, vol.205
, pp. 2409-2417
-
-
El-Osta, A.1
-
94
-
-
84925519612
-
Epigenetic mechanisms in diabetic complications and metabolic memory
-
Reddy, M. A., Zhang, E. & Natarajan, R. Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 58, 443-455 (2015).
-
(2015)
Diabetologia
, vol.58
, pp. 443-455
-
-
Reddy, M.A.1
Zhang, E.2
Natarajan, R.3
-
95
-
-
14044252841
-
Gene-nutrient interactions in one-carbon metabolism
-
Friso, S. & Choi, S. W. Gene-nutrient interactions in one-carbon metabolism. Curr. Drug Metab. 6, 37-46 (2005).
-
(2005)
Curr. Drug Metab.
, vol.6
, pp. 37-46
-
-
Friso, S.1
Choi, S.W.2
-
96
-
-
33745074420
-
Impact of diets and nutrients/drugs on early epigenetic programming
-
Junien, C. Impact of diets and nutrients/drugs on early epigenetic programming. J. Inherit. Metab. Dis. 29, 359-365 (2006).
-
(2006)
J. Inherit. Metab. Dis.
, vol.29
, pp. 359-365
-
-
Junien, C.1
-
97
-
-
84903957218
-
MTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress
-
Grahammer, F. et al. mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. Proc. Natl Acad. Sci. USA 111, E2817-E2826 (2014).
-
(2014)
Proc. Natl Acad. Sci. USA
, vol.111
, pp. E2817-E2826
-
-
Grahammer, F.1
-
98
-
-
84878269299
-
MiR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
-
Zhong, X. et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56, 663-674 (2013).
-
(2013)
Diabetologia
, vol.56
, pp. 663-674
-
-
Zhong, X.1
-
99
-
-
84980383473
-
Roles of mTOR complexes in the kidney: Implications for renal disease and transplantation
-
Fantus, D., Rogers, N. M., Grahammer, F., Huber, T. B. & Thomson, A. W. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. Nat. Rev. Nephrol. 12, 587-609 (2016).
-
(2016)
Nat. Rev. Nephrol.
, vol.12
, pp. 587-609
-
-
Fantus, D.1
Rogers, N.M.2
Grahammer, F.3
Huber, T.B.4
Thomson, A.W.5
-
100
-
-
79957881425
-
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
-
Godel, M. et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J. Clin. Invest. 121, 2197-2209 (2011).
-
(2011)
J. Clin. Invest.
, vol.121
, pp. 2197-2209
-
-
Godel, M.1
-
101
-
-
85017435939
-
Targeting mTOR signaling can prevent the progression of FSGS
-
Zschiedrich, S. et al. Targeting mTOR signaling can prevent the progression of FSGS. J. Am. Soc. Nephrol. 28, 2144-2157 (2017).
-
(2017)
J. Am. Soc. Nephrol.
, vol.28
, pp. 2144-2157
-
-
Zschiedrich, S.1
-
102
-
-
85018371570
-
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
-
Qi, W. et al. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat. Med. 23, 753-762 (2017).
-
(2017)
Nat. Med.
, vol.23
, pp. 753-762
-
-
Qi, W.1
-
103
-
-
84978765819
-
Obesity-related glomerulopathy: Clinical and pathologic characteristics and pathogenesis
-
D'Agati, V. D. et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat. Rev. Nephrol 12, 453-471 (2016).
-
(2016)
Nat. Rev. Nephrol
, vol.12
, pp. 453-471
-
-
D'Agati, V.D.1
-
104
-
-
85044198576
-
Reproductive health and pregnancy in women with chronic kidney disease
-
Wiles, K. S., Nelson-Piercy, C. & Bramham, K. Reproductive health and pregnancy in women with chronic kidney disease. Nat. Rev. Nephrol. https://doi. org/10. 1038/nrneph. 2017. 187 (2018).
-
(2018)
Nat. Rev. Nephrol.
-
-
Wiles, K.S.1
Nelson-Piercy, C.2
Bramham, K.3
-
105
-
-
84948704559
-
Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456, 586 German T2DM patients
-
Wilke, T. et al. Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456, 586 German T2DM patients. J. Diabetes Compl. 29, 1015-1023 (2015).
-
(2015)
J. Diabetes Compl.
, vol.29
, pp. 1015-1023
-
-
Wilke, T.1
-
106
-
-
80052520550
-
Kidney biopsy in patients with diabetes mellitus
-
Haider, D. G. et al. Kidney biopsy in patients with diabetes mellitus. Clin. Nephrol. 76, 180-185 (2011).
-
(2011)
Clin. Nephrol.
, vol.76
, pp. 180-185
-
-
Haider, D.G.1
-
107
-
-
85018466835
-
Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012
-
Mayer-Davis, E. J. et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N. Engl. J. Med. 376, 1419-1429 (2017).
-
(2017)
N. Engl. J. Med.
, vol.376
, pp. 1419-1429
-
-
Mayer-Davis, E.J.1
-
108
-
-
84873407159
-
Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: A clinicopathological study of 216 cases
-
Zhuo, L., Ren, W., Li, W., Zou, G. & Lu, J. Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases. Int. Urol. Nephrol. 45, 173-179 (2013).
-
(2013)
Int. Urol. Nephrol.
, vol.45
, pp. 173-179
-
-
Zhuo, L.1
Ren, W.2
Li, W.3
Zou, G.4
Lu, J.5
-
109
-
-
84906277024
-
Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: Recommendations and future directions
-
Sharif, A. et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am. J. Transplant. 14, 1992-2000 (2014).
-
(2014)
Am. J. Transplant.
, vol.14
, pp. 1992-2000
-
-
Sharif, A.1
-
110
-
-
54949144323
-
Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients
-
International Diabetic Nephropathy Study.
-
Steinke, J. M. & Mauer, M., International Diabetic Nephropathy Study. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr. Endocrinol. Rev. 5(Suppl. 4), 958-963 (2008).
-
(2008)
Pediatr. Endocrinol. Rev.
, vol.5
, pp. 958-963
-
-
Steinke, J.M.1
Mauer, M.2
-
111
-
-
84897910668
-
Cystatin C-and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U
-
Tsai, C. W., Grams, M. E., Inker, L. A., Coresh, J. & Selvin, E. Cystatin C-and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U. S. Diabetes Care 37, 1002-1008 (2014).
-
(2014)
S. Diabetes Care
, vol.37
, pp. 1002-1008
-
-
Tsai, C.W.1
Grams, M.E.2
Inker, L.A.3
Coresh, J.4
Selvin, E.5
-
112
-
-
85035241193
-
Chronic kidney disease
-
Romagnani, P. et al. Chronic kidney disease. Nat. Rev. Dis. Primer 3, 17088 (2017).
-
(2017)
Nat. Rev. Dis. Primer
, vol.3
, pp. 17088
-
-
Romagnani, P.1
-
113
-
-
85031670298
-
A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome
-
Nair, V. et al. A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. Kidney Int. 93, 439-449 (2018).
-
(2018)
Kidney Int.
, vol.93
, pp. 439-449
-
-
Nair, V.1
-
114
-
-
84883309399
-
Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes
-
Weil, E. J. et al. Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes. Diabetes 62, 3224-3231 (2013).
-
(2013)
Diabetes
, vol.62
, pp. 3224-3231
-
-
Weil, E.J.1
-
115
-
-
85020544173
-
Single-nephron glomerular filtration rate in healthy adults
-
Denic, A. et al. Single-nephron glomerular filtration rate in healthy adults. N. Engl. J. Med. 376, 2349-2357 (2017).
-
(2017)
N. Engl. J. Med.
, vol.376
, pp. 2349-2357
-
-
Denic, A.1
-
116
-
-
84860279587
-
Glomerular hyperfiltration: Definitions, mechanisms and clinical implications
-
Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B. & Schrier, R. W. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat. Rev. Nephrol. 8, 293-300 (2012).
-
(2012)
Nat. Rev. Nephrol.
, vol.8
, pp. 293-300
-
-
Helal, I.1
Fick-Brosnahan, G.M.2
Reed-Gitomer, B.3
Schrier, R.W.4
-
117
-
-
0032771641
-
What makes cells grow larger and how do they do it? Renal hypertrophy revisited
-
Preisig, P. What makes cells grow larger and how do they do it? Renal hypertrophy revisited. Exp. Nephrol. 7, 273-283 (1999).
-
(1999)
Exp. Nephrol.
, vol.7
, pp. 273-283
-
-
Preisig, P.1
-
118
-
-
85026894560
-
Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: The Gonryo study
-
Iwai, T. et al. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study. Clin. Exp. Nephrol. https://doi. org/10. 1007/s10157-017-1451-4 (2017).
-
(2017)
Clin. Exp. Nephrol.
-
-
Iwai, T.1
-
119
-
-
79955837851
-
Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease
-
Chang, T. I. et al. Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res. Clin. Pract. 92, 198-204 (2011).
-
(2011)
Diabetes Res. Clin. Pract.
, vol.92
, pp. 198-204
-
-
Chang, T.I.1
-
120
-
-
85035195459
-
The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'. Implications for pre-clinical research and drug testing
-
Anguiano Gomez, L., Lei, Y., Devarapu, S. K. & Anders, H. J. The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'. Implications for pre-clinical research and drug testing. Nephrol. Dial. Transplant. https:// doi. org/10. 1093/ndt/gfx219 (2017).
-
(2017)
Nephrol. Dial. Transplant.
-
-
Anguiano Gomez, L.1
Lei, Y.2
Devarapu, S.K.3
Anders, H.J.4
-
121
-
-
84872047522
-
Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli
-
Hodgin, J. B. et al. Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes 62, 299-308 (2013).
-
(2013)
Diabetes
, vol.62
, pp. 299-308
-
-
Hodgin, J.B.1
-
122
-
-
85031747589
-
The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease
-
Pollock, C. et al. The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease. Kidney Int. Suppl. 7, 130-137 (2017).
-
(2017)
Kidney Int. Suppl.
, vol.7
, pp. 130-137
-
-
Pollock, C.1
-
123
-
-
84955324880
-
Hurdles to the introduction of new therapies for immunemediated kidney diseases
-
Anders, H. J., Jayne, D. R. & Rovin, B. H. Hurdles to the introduction of new therapies for immunemediated kidney diseases. Nat. Rev. Nephrol. 12, 205-216 (2016).
-
(2016)
Nat. Rev. Nephrol.
, vol.12
, pp. 205-216
-
-
Anders, H.J.1
Jayne, D.R.2
Rovin, B.H.3
-
124
-
-
85020353485
-
Risk factors for severe bleeding complications in percutaneous renal biopsy
-
Xu, D. M., Chen, M., Zhou, F. D. & Zhao, M. H. Risk factors for severe bleeding complications in percutaneous renal biopsy. Am. J. Med. Sci. 353, 230-235 (2017).
-
(2017)
Am. J. Med. Sci.
, vol.353
, pp. 230-235
-
-
Xu, D.M.1
Chen, M.2
Zhou, F.D.3
Zhao, M.H.4
-
125
-
-
85009742361
-
Kidney disease and obesity: Epidemiology, mechanisms and treatment
-
Camara, N. O., Iseki, K., Kramer, H., Liu, Z. H. & Sharma, K. Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat. Rev. Nephrol. 13, 181-190 (2017).
-
(2017)
Nat. Rev. Nephrol.
, vol.13
, pp. 181-190
-
-
Camara, N.O.1
Iseki, K.2
Kramer, H.3
Liu, Z.H.4
Sharma, K.5
-
126
-
-
72049119396
-
Mouse models of diabetic nephropathy
-
Brosius, F. C. et al. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 20, 2503-2512 (2009).
-
(2009)
J. Am. Soc. Nephrol.
, vol.20
, pp. 2503-2512
-
-
Brosius, F.C.1
-
127
-
-
0034528381
-
Prevalence of non-diabetic renal disease among African-American patients with type II diabetes mellitus
-
Nzerue, C. M. et al. Prevalence of non-diabetic renal disease among African-American patients with type II diabetes mellitus. Scand. J. Urol. Nephrol. 34, 331-335 (2000).
-
(2000)
Scand. J. Urol. Nephrol.
, vol.34
, pp. 331-335
-
-
Nzerue, C.M.1
-
128
-
-
34250841698
-
Prevalence of nondiabetic renal disease in diabetic patients
-
Pham, T. T., Sim, J. J., Kujubu, D. A., Liu, I. L. & Kumar, V. A. Prevalence of nondiabetic renal disease in diabetic patients. Am. J. Nephrol. 27, 322-328 (2007).
-
(2007)
Am. J. Nephrol.
, vol.27
, pp. 322-328
-
-
Pham, T.T.1
Sim, J.J.2
Kujubu, D.A.3
Liu, I.L.4
Kumar, V.A.5
-
129
-
-
0036194517
-
Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
-
Mazzucco, G. et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am. J. Kidney Dis. 39, 713-720 (2002).
-
(2002)
Am. J. Kidney Dis.
, vol.39
, pp. 713-720
-
-
Mazzucco, G.1
-
130
-
-
80052223047
-
Clinical versus histological diagnosis of diabetic nephropathy-is renal biopsy required in type 2 diabetic patients with renal disease?
-
Biesenbach, G., Bodlaj, G., Pieringer, H. & Sedlak, M. Clinical versus histological diagnosis of diabetic nephropathy-is renal biopsy required in type 2 diabetic patients with renal disease? QJM 104, 771-774 (2011).
-
(2011)
QJM
, vol.104
, pp. 771-774
-
-
Biesenbach, G.1
Bodlaj, G.2
Pieringer, H.3
Sedlak, M.4
-
131
-
-
0026551223
-
Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus
-
Richards, N. T. et al. Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol. Dial Transplant 7, 397-399 (1992).
-
(1992)
Nephrol. Dial Transplant
, vol.7
, pp. 397-399
-
-
Richards, N.T.1
-
132
-
-
0033065531
-
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis
-
Cordonnier, D. J. et al. Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. J. Am. Soc. Nephrol. 10, 1253-1263 (1999).
-
(1999)
J. Am. Soc. Nephrol.
, vol.10
, pp. 1253-1263
-
-
Cordonnier, D.J.1
-
133
-
-
0026583232
-
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
-
Parving, H. H. et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 41, 758-762 (1992).
-
(1992)
Kidney Int.
, vol.41
, pp. 758-762
-
-
Parving, H.H.1
-
134
-
-
0033797959
-
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy
-
Christensen, P. K., Larsen, S., Horn, T., Olsen, S. & Parving, H. H. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int. 58, 1719-1731 (2000).
-
(2000)
Kidney Int.
, vol.58
, pp. 1719-1731
-
-
Christensen, P.K.1
Larsen, S.2
Horn, T.3
Olsen, S.4
Parving, H.H.5
-
135
-
-
0034934330
-
Retinopathy, hematuria, and diabetic nephropathy
-
Izzedine, H., Fongoro, S., Pajot, O., Beaufils, H. & Deray, G. Retinopathy, hematuria, and diabetic nephropathy. Nephron 88, 382-383 (2001).
-
(2001)
Nephron
, vol.88
, pp. 382-383
-
-
Izzedine, H.1
Fongoro, S.2
Pajot, O.3
Beaufils, H.4
Deray, G.5
-
136
-
-
85045291291
-
Predictive factors for non-diabetic nephropathy in diabetic patients. the utility of renal biopsy
-
Bermejo, S. et al. Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy. Nefrologia 36, 535-544 (2016).
-
(2016)
Nefrologia
, vol.36
, pp. 535-544
-
-
Bermejo, S.1
-
137
-
-
0036837048
-
Is there a need for changes in renal biopsy criteria in proteinuria in type 2 diabetes?
-
Serra, A., Romero, R., Bayes, B., Lopez, D. & Bonet, J. Is there a need for changes in renal biopsy criteria in proteinuria in type 2 diabetes? Diabetes Res. Clin. Pract. 58, 149-153 (2002).
-
(2002)
Diabetes Res. Clin. Pract.
, vol.58
, pp. 149-153
-
-
Serra, A.1
Romero, R.2
Bayes, B.3
Lopez, D.4
Bonet, J.5
-
138
-
-
0036043660
-
Renal histological lesions in patients with type II diabetes mellitus [Spanish]
-
Castellano, I., Covarsi, A., Novillo, R., Gomez-Martino, J. R. & Ferrando, L. Renal histological lesions in patients with type II diabetes mellitus [Spanish]. Nefrologia 22, 162-169 (2002).
-
(2002)
Nefrologia
, vol.22
, pp. 162-169
-
-
Castellano, I.1
Covarsi, A.2
Novillo, R.3
Gomez-Martino, J.R.4
Ferrando, L.5
-
139
-
-
11244272941
-
The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000
-
Rychlik, I. et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol. Dial. Transplant. 19, 3040-3049 (2004).
-
(2004)
Nephrol. Dial. Transplant.
, vol.19
, pp. 3040-3049
-
-
Rychlik, I.1
-
140
-
-
85047104701
-
Nondiabetic renal disease in patients with type 2 diabetes
-
Mami, I. et al. Nondiabetic renal disease in patients with type 2 diabetes. Saudi J. Kidney Dis. Transpl. 28, 842-850 (2017).
-
(2017)
Saudi J. Kidney Dis. Transpl.
, vol.28
, pp. 842-850
-
-
Mami, I.1
-
141
-
-
34248579004
-
Renal biopsy findings in diabetes mellitus [French]
-
Kharrat, M. et al. Renal biopsy findings in diabetes mellitus [French]. Tunis Med. 85, 216-219 (2007).
-
(2007)
Tunis Med.
, vol.85
, pp. 216-219
-
-
Kharrat, M.1
-
142
-
-
70350623080
-
Renal biopsy in patients with type 2 diabetes mellitus: Indications and nature of the lesions
-
Ghani, A. A., Al Waheeb, S., Al Sahow, A. & Hussain, N. Renal biopsy in patients with type 2 diabetes mellitus: indications and nature of the lesions. Ann. Saudi Med. 29, 450-453 (2009).
-
(2009)
Ann. Saudi Med.
, vol.29
, pp. 450-453
-
-
Ghani, A.A.1
Al Waheeb, S.2
Al Sahow, A.3
Hussain, N.4
-
143
-
-
79958140559
-
Pathology of nondiabetic glomerular disease among adult Iraqi patients from a single center
-
Hashim Al-Saedi, A. J. Pathology of nondiabetic glomerular disease among adult Iraqi patients from a single center. Saudi J. Kidney Dis. Transpl. 20, 858-861 (2009).
-
(2009)
Saudi J. Kidney Dis. Transpl.
, vol.20
, pp. 858-861
-
-
Hashim Al-Saedi, A.J.1
-
144
-
-
33845676163
-
Non diabetic renal disease in type 2 diabetes mellitus
-
Soni, S. S., Gowrishankar, S., Kishan, A. G. & Raman, A. Non diabetic renal disease in type 2 diabetes mellitus. Nephrology 11, 533-537 (2006).
-
(2006)
Nephrology
, vol.11
, pp. 533-537
-
-
Soni, S.S.1
Gowrishankar, S.2
Kishan, A.G.3
Raman, A.4
-
145
-
-
24044543553
-
Rapidly progressive renal failure in type 2 diabetes in the tropical environment: A clinico-pathological study
-
Moger, V. et al. Rapidly progressive renal failure in type 2 diabetes in the tropical environment: a clinico-pathological study. Ren. Fail. 27, 595-600 (2005).
-
(2005)
Ren. Fail.
, vol.27
, pp. 595-600
-
-
Moger, V.1
-
146
-
-
34249818454
-
Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients
-
Prakash, J. et al. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients. J. Assoc. Physicians India 55, 412-416 (2007).
-
(2007)
J. Assoc. Physicians India
, vol.55
, pp. 412-416
-
-
Prakash, J.1
-
147
-
-
0036769974
-
Prevalence of non-diabetic renal disease in type 2 diabetic patients in a diabetes centre in Southern India
-
Premalatha, G. et al. Prevalence of non-diabetic renal disease in type 2 diabetic patients in a diabetes centre in Southern India. J. Assoc. Physicians India 50, 1135-1139 (2002).
-
(2002)
J. Assoc. Physicians India
, vol.50
, pp. 1135-1139
-
-
Premalatha, G.1
-
148
-
-
73349121664
-
An evaluation of renal biopsy in type-II diabetic patients
-
Arif, M., Arif, M. K. & Arif, M. S. An evaluation of renal biopsy in type-II diabetic patients. J. Coll. Physicians Surg. Pak 19, 627-631 (2009).
-
(2009)
J. Coll. Physicians Surg. Pak
, vol.19
, pp. 627-631
-
-
Arif, M.1
Arif, M.K.2
Arif, M.S.3
-
149
-
-
84871701298
-
Non-diabetic renal disease in patients with type-2 diabetes mellitus
-
Yaqub, S., Kashif, W. & Hussain, S. A. Non-diabetic renal disease in patients with type-2 diabetes mellitus. Saudi J. Kidney Dis. Transpl 23, 1000-1007 (2012).
-
(2012)
Saudi J. Kidney Dis. Transpl
, vol.23
, pp. 1000-1007
-
-
Yaqub, S.1
Kashif, W.2
Hussain, S.A.3
-
150
-
-
84863393841
-
Clinical predictors of non-diabetic renal disease and role of renal biopsy in diabetic patients with renal involvement: A single centre review
-
Chong, Y. B. et al. Clinical predictors of non-diabetic renal disease and role of renal biopsy in diabetic patients with renal involvement: a single centre review. Ren. Fail. 34, 323-328 (2012).
-
(2012)
Ren. Fail.
, vol.34
, pp. 323-328
-
-
Chong, Y.B.1
-
151
-
-
84990837137
-
Clinicopathological characteristics of nondiabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: A retrospective analysis of 273 cases
-
Liu, S. et al. Clinicopathological characteristics of nondiabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Int. Urol. Nephrol. 48, 1691-1698 (2016).
-
(2016)
Int. Urol. Nephrol.
, vol.48
, pp. 1691-1698
-
-
Liu, S.1
-
152
-
-
78651344471
-
Nondiabetic renal disease in type 2 diabetic patients: A review of our experience in 220 cases
-
Bi, H. et al. Nondiabetic renal disease in type 2 diabetic patients: a review of our experience in 220 cases. Ren. Fail. 33, 26-30 (2011).
-
(2011)
Ren. Fail.
, vol.33
, pp. 26-30
-
-
Bi, H.1
-
153
-
-
78650647192
-
Renal biopsy in type 2 diabetes: Timing of complications and evaluating of safety in Chinese patients
-
Zhang, P. P. et al. Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients. Nephrology 16, 100-105 (2011).
-
(2011)
Nephrology
, vol.16
, pp. 100-105
-
-
Zhang, P.P.1
-
154
-
-
77649187442
-
Prevalence of non-diabetic renal disease in patients with type 2 diabetes
-
Mou, S. et al. Prevalence of non-diabetic renal disease in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 87, 354-359 (2010).
-
(2010)
Diabetes Res. Clin. Pract.
, vol.87
, pp. 354-359
-
-
Mou, S.1
-
155
-
-
0036582704
-
Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies
-
Wong, T. Y. et al. Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies. Diabetes Care 25, 900-905 (2002).
-
(2002)
Diabetes Care
, vol.25
, pp. 900-905
-
-
Wong, T.Y.1
-
156
-
-
34248395631
-
Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: A report of 52 cases
-
Huang, F. et al. Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: a report of 52 cases. Clin. Nephrol. 67, 293-297 (2007).
-
(2007)
Clin. Nephrol.
, vol.67
, pp. 293-297
-
-
Huang, F.1
-
157
-
-
0030665196
-
Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus
-
Mak, S. K. et al. Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Nephrol. Dial. Transplant. 12, 2588-2591 (1997).
-
(1997)
Nephrol. Dial. Transplant.
, vol.12
, pp. 2588-2591
-
-
Mak, S.K.1
-
158
-
-
67749088600
-
Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease
-
Lin, Y. L., Peng, S. J., Ferng, S. H., Tzen, C. Y. & Yang, C. S. Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease. Int. J. Clin. Pract. 63, 1167-1176 (2009).
-
(2009)
Int. J. Clin. Pract.
, vol.63
, pp. 1167-1176
-
-
Lin, Y.L.1
Peng, S.J.2
Ferng, S.H.3
Tzen, C.Y.4
Yang, C.S.5
-
159
-
-
84873203852
-
Significance of renal biopsy in patients with presumed diabetic nephropathy
-
Harada, K. et al. Significance of renal biopsy in patients with presumed diabetic nephropathy. J. Diabetes Investig. 4, 88-93 (2013).
-
(2013)
J. Diabetes Investig.
, vol.4
, pp. 88-93
-
-
Harada, K.1
-
160
-
-
0026134517
-
Nondiabetic renal disease complicating diabetic nephropathy
-
Hironaka, K., Makino, H., Ikeda, S., Haramoto, T. & Ota, Z. Nondiabetic renal disease complicating diabetic nephropathy. J. Diabet Compl. 5, 148-149 (1991).
-
(1991)
J. Diabet Compl.
, vol.5
, pp. 148-149
-
-
Hironaka, K.1
Makino, H.2
Ikeda, S.3
Haramoto, T.4
Ota, Z.5
-
161
-
-
23744472597
-
Clinical features of non-diabetic renal diseases in patients with type 2 diabetes
-
Tone, A. et al. Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 69, 237-242 (2005).
-
(2005)
Diabetes Res. Clin. Pract.
, vol.69
, pp. 237-242
-
-
Tone, A.1
-
162
-
-
47949126901
-
Microscopic hematuria and diabetic glomerulosclerosis-clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria
-
Akimoto, T. et al. Microscopic hematuria and diabetic glomerulosclerosis-clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria. Nephron Clin. Pract. 109, c119 (2008).
-
(2008)
Nephron Clin. Pract.
, vol.109
, pp. c119
-
-
Akimoto, T.1
-
163
-
-
0033176345
-
Non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus
-
Lee, E. Y., Chung, C. H. & Choi, S. O. Non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Yonsei Med. J. 40, 321-326 (1999).
-
(1999)
Yonsei Med. J.
, vol.40
, pp. 321-326
-
-
Lee, E.Y.1
Chung, C.H.2
Choi, S.O.3
|